Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI).

Chen, Shuxia

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI). [electronic resource] - Medical science monitor : international medical journal of experimental and clinical research Aug 2017 - 3824-3830 p. digital

Publication Type: Journal Article

1643-3750

10.12659/msm.903054 doi


Adenosine--analogs & derivatives
Aged
Blood Platelets--drug effects
Clopidogrel
Coronary Disease--drug therapy
Cytochrome P-450 CYP2C19--genetics
Cytochrome P-450 CYP2C19 Inhibitors--pharmacology
Drug Therapy, Combination
Drugs, Chinese Herbal--therapeutic use
Female
Humans
Male
Middle Aged
Mutation
Percutaneous Coronary Intervention--adverse effects
Platelet Aggregation Inhibitors--therapeutic use
Ticagrelor
Ticlopidine--analogs & derivatives